EDITORIAL SECTION

Articles

What Are the Implications of the Changing Regulatory Landscape in Europe?

In an age characterized by technological progress changing geopolitical scenarios and an increasing focus on sustainability businesses in Europe are grappling with an intricate network of regulatory shifts

The Future of Pharma Data Management: Creating Unified Platforms for Innovation

Ask a European pharmaceutical executive where the companys data actually lives and the honest answer is usually in about forty places under a dozen owners described in half a dozen vocabularies Research holds assay and translational data Clinical holds trial and subject data

Pharma ABM Strategies for B2B Growth: Precision Targeting for Key Accounts

The pharmaceutical industry is making significant strides changing the way that company ies are identified engaged and converted into high value business customers In todays datadriven competitive world traditional mass marketing strategies are no longer effective In todays day and age pharmaceutical companies are embracing very personalized relationships ROI measurement and the expansion of their...

Navigating European Pharma Regulations: A B2B Perspective

The pharmaceutical industry in the European region practices one of the most regulating laws in the entire world Therefore regulations encompassing these areas are of prime importance for BB companies that need to achieve market entry and maintain compliance Thus this guide is meant to decompartmentalize the array of European pharma regulations and create

Why is Pharmacogenetics and Pharmacogenomics Important?

In a world of increasingly personalized medicine the fields of pharmacogenetics and pharmacogenomics are gaining importance These disciplines explore the relationship between an individuals genetic makeup

The Integration of Genomics into European Drug Development: Advances and Implications

Genomics in which genes and their novelty are discovered and taken into account as tools has recently risen as a strong tool in the drug discovery process Applying genomics into drug development in Europe has therefore provided a way towards more effective and safer drugs In light of the present analysis this article addresses how genomics is transforming drug development in Europe and its benefit...

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys